YU.V. SENKINA, A.A. POPOV, T.A. GLEBOV

 Moscow Regional Scientific Research Institute of Obstetrics and Gynecology named after Acad. V.I. Krasnopolsky, Moscow

Contact details:

Senkina Yu.V. — post-graduate student of the Department of Operative Gynecology with Oncogynecology and day hospital

Address: 22a Pokrovka St., 101000 Moscow, Russian Federation, tel.: +7-915-008-43-09, e-mail: julia11_04@mail.ru

 The purpose — to evaluate the surgical outcomes of robot-assisted panhysterectomy with or without pelvic lymphadenectomy in the surgical treatment of patients with morbid obesity.

Material and methods. We conducted a retrospective analysis of the clinical characteristics and treatment of 85 patients with endometrial cancer suffering from morbid obesity. The patients were treated at the Department of Operative Gynecology with Oncogynecology and Day Hospital of Moscow Research Institute of Obstetrics and Gynecology named after Acad. V.I. Krasnopolsky from 2013 to 2025.

Results. Based on individual and group medical records, we analyzed the medical data of 85 patients with endometrial cancer. The average BMI of patients who underwent lymphadenectomy was 48.2 kg/m². Pelvic lymphadenectomy was performed in 17 patients (20.00%). One case of conversion due to bleeding was recorded in a patient with an extremely high BMI (>54 kg/m²).

Conclusion. Robot-assisted laparoscopy is safe for treating endometrial cancer in morbidly obese patients. The robotic system allows for a higher likelihood of complete surgical treatment in patients with morbid obesity.

Key words: robotic surgery, endometrial cancer, morbid obesity.

REFERENCES

1. Gu B., Shang X., Yan M., Li X., Wang W., Wang Q., Zhang C. Variations in incidence and mortality rates of endometrial cancer at the global, regional, and national levels, 1990–2019. Gynecol. Oncol, 2021, vol. 161 (2), pp. 573–580.
2. Corr B.R., Erickson B.K., Barber E.L., Fisher C.M., Slomovitz B. Advances in the management of endometrial cancer. BMJ, 2025, vol. 388, p. e080978.
3. Merabishvili V.M., Berlev I.V., Urmancheyeva A.F., Bakhidze E.V., Ul′rikh E.A. Malignant neoplasms of the vulva: epidemiology and survival of patients in Russia (a clinical-population study). Opukholi zhenskoy reproduktivnoy sistemy, 2024, vol. 20, no. 4, pp. 33–43 (in Russ.).
4. Alfёrova V.I., Mustafina S.V. Prevalence of obesity in the adult population of the Russian Federation (literature review). Ozhireniye i metabolizm, 2022, vol. 19, no. 1, pp. 96–105 (in Russ.).
5. Okunogbe A., Nugent R., Spencer G., Powis J., Ralston J., Wilding J. Economic impacts of overweight and obesity: current and future estimates for 161 countries. BMJ Glob. Health, 2022, vol. 7 (9), p. e009773.
6. Mahdi H., Jernigan A.M., Aljebori Q., Lockhart D., Moslemi-Kebria M. The impact of obesity on the 30-day morbidity and mortality after surgery for endometrial cancer. J. Minim. Invasive Gynecol, 2015, vol. 22 (1), pp. 94–102.
7. Dedov I.I., Mel′nichenko G.A., Shestakova M.V., Troshina E.A., Mazurina N.V., Shestakova E.A. et al. National clinical guidelines for the treatment of morbid obesity in adults. 3rd revision (treatment of morbid obesity in adults). Ozhireniye i metabolizm, 2018, vol. 15, no. 1, pp. 53–70.
8. Zabolotskikh I.B., Anisimov M.A., Gorobets E.S., Gritsan A.I., Lebedinskiy K.M., Musayeva T.S. et al. Perioperative management of patients with concomitant morbid obesity. Guidelines of the All-Russian Public Organization «Federation of Anesthesiologists and Resuscitators». Vestnik intensivnoy terapii im. A.I. Saltanova, 2021, no. 1, pp. 7–18 (in Russ.).
9. Popov A.A., Loginova E.A., Slobodyanyuk B.A., Golovin A.A., Budykina T.S., Lysenko S.N. Hysterectomy in patients with morbid obesity. Kubanskiy nauchnyy meditsinskiy vestnik, 2016, no. 1, pp. 161–168 (in Russ.).
10. Concin N., Matias-Guiu X., Cibula D., Colombo N., Creutzberg C.L., Ledermann J. et al. ESGO-ESTRO-ESP guidelines for the management of patients with endometrial carcinoma: update 2025. Lancet Oncol, 2025, vol. 26 (8), pp. e423–e435.
11. Uwins C., Patel H., Prakash Bhandoria G., Butler-Manuel S., Tailor A., Ellis P., Chatterjee J. Laparoscopic and robotic surgery for endometrial and cervical cancer. Clin. Oncol. (R Coll. Radiol.), 2021, vol. 33 (9), pp. e372–e382.
12. Crosbie E.J., Kitson S.J., McAlpine J.N., Mukhopadhyay A., Powell M.E., Singh N. Endometrial cancer. Lancet, 2022, vol. 399 (10333), pp. 1412–1428.
13. Walker J.L., Piedmonte M.R., Spirtos N.M., Eisenkop S.M., Schlaerth J.B., Mannel R.S. et al. Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2. J. Clin. Oncol, 2009, vol. 27 (32), pp. 5331–5336.
14. Gunderson C.C., Java J., Moore K.N., Walker J.L. The impact of obesity on surgical staging, complications, and survival with uterine cancer: a Gynecologic Oncology Group LAP2 ancillary data study. Gynecol. Oncol, 2014, vol. 133 (1), pp. 23–27.
15. Bijen C.B., de Bock G.H., Vermeulen K.M., Arts H.J., ter Brugge H.G., van der Sijde R. et al. Laparoscopic hysterectomy is preferred over laparotomy in early endometrial cancer patients, however not cost effective in the very obese. Eur. J. Cancer, 2011, vol. 47 (14), pp. 2158–2165.
16. Berlev I.V., Ul′rikh E.A., Aminzhon B.S., Nekrasova E.A., Mikaya N.A., Urmancheyeva A.F., Tsypurdeyeva A.A. Laparoscopic hysterectomy for endometrial cancer in obese patients. Zhurnal akusherstva i zhenskikh bolezney, 2014, vol. 63, no. 6, pp. 21–31 (in Russ.).
17. Marek R., Dzvinčuk P., Hambálek J., Maděrka M., Jančeková V., Kolářová V. et al. Robotic paraaortic lymphadenectomy in oncogynecology. Double side docking of daVinci S system increases the success rates of high paraaortic lymph node dissection in endometrial cancer. Ceska Gynekol, 2019, vol. 84 (1), pp. 4–17.
18. Fornalik H., Zore T., Fornalik N., Foster T., Katschke A., Wright G. Can teamwork and high-volume experience overcome challenges of lymphadenectomy in morbidly obese patients (body mass index of 40 kg/m2 or greater) with endometrial cancer? A cohort study of robotics and laparotomy and review of literature. Int. J. Gynecol. Cancer, 2018, vol. 28 (5), pp. 959–966.
19. Asanoma K., Yahata H., Okugawa K., Ohgami T., Yasunaga M., Kodama K. et al. Impact of obesity on robotic-assisted surgery in patients with stage IA endometrial cancer and a low risk of recurrence: An institutional study. J. Obstet. Gynaecol. Res, 2022, vol. 48 (12), pp. 3226–3232.
20. Gallo T., Kashani S., Patel D.A., Elsahwi K., Silasi D.A., Azodi M. Robotic-assisted laparoscopic hysterectomy: outcomes in obese and morbidly obese patients. JSLS, 2012, vol. 16 (3), pp. 421–427.
21. Brunes M., Johannesson U., Häbel H., Söderberg M.W., Ek M. Effects of obesity on peri- and postoperative outcomes in patients undergoing robotic versus conventional hysterectomy. J. Minim. Invasive Gynecol, 2021, vol. 28 (2), pp. 228–236.
22. Haveman I., van Weelden W.J., Roovers E.A., Kraayenbrink A.A., Dijkhuizen F.P.H.L.J. Robot-assisted total laparoscopic hysterectomy in different classes of obesity: a cohort study. JSLS, 2022, vol. 26 (1). e2021.00077.
23. Ouasti S., Ilic J., Mimoun C., Bendifallah S., Huchon C., Ouldamer L. et al. Adherence to ESGO guidelines and impact on survival in obese patients with endometrial cancer: a multicentric retrospective study. Int. J. Gynecol. Cancer, 2023, vol. 33 (12), pp. 1950–1956.
24. Gracia M., García-Santos J., Ramirez M., Bellón M., Herraiz M.A., Coronado P.J. Value of robotic surgery in endometrial cancer by body mass index. Int. J. Gynaecol. Obstet., 2020, vol. 150 (3), pp. 398–405.